Acutus Medical, Inc. AFIB
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 203.66% | 155.63% | 172.41% | 191.87% | -52.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 203.66% | 155.63% | 172.41% | 191.87% | -52.68% |
| Cost of Revenue | 148.38% | 55.37% | 76.89% | 73.14% | -59.04% |
| Gross Profit | 951.69% | 134.13% | 66.11% | 96.55% | 88.86% |
| SG&A Expenses | -44.00% | -1.53% | -32.16% | -25.38% | -34.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.87% | 12.69% | -0.43% | -7.03% | -54.98% |
| Operating Income | 71.34% | 55.16% | 50.70% | 46.38% | 55.91% |
| Income Before Tax | 33.79% | 57.46% | 91.45% | 51.99% | -113.03% |
| Income Tax Expenses | -- | -- | -- | -- | -23.17% |
| Earnings from Continuing Operations | 35.83% | 57.46% | 91.45% | 51.99% | -113.52% |
| Earnings from Discontinued Operations | 99.70% | 57.67% | 96.09% | 103.61% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 95.84% | 57.64% | 95.02% | 90.07% | -323.49% |
| EBIT | 71.34% | 55.16% | 50.70% | 46.38% | 55.91% |
| EBITDA | 72.24% | 55.27% | 50.86% | 46.96% | 50.41% |
| EPS Basic | 95.90% | 58.39% | 95.13% | 90.37% | -317.13% |
| Normalized Basic EPS | 50.50% | 30.05% | 50.58% | 11.23% | 64.13% |
| EPS Diluted | 95.90% | 58.39% | 95.13% | 90.37% | -383.98% |
| Normalized Diluted EPS | 50.50% | 30.05% | 50.58% | 11.23% | 53.10% |
| Average Basic Shares Outstanding | 1.57% | 1.83% | 2.35% | 3.23% | 2.94% |
| Average Diluted Shares Outstanding | 1.57% | 1.83% | 2.35% | 3.23% | -21.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |